Duloxetine inhibits the reuptake of serotonin and norepinephrine (NE) in the central nervous system.
The analgesic properties of duloxetine in the treatment of diabetic neuropathy and central pain syndromes such as fibromyalgia are believed to be due to sodium ion channel blockade [REF].